Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 3

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Gynecologic 1

Conditions

Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Endometrial Serous Adenocarcinoma 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 59Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Bevacizumab 40Reverse Transcriptase Polymerase Chain Reaction 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Hepatectomy 25Therapeutics 24Neoadjuvant Therapy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Observational × Transcriptome × Clear all
NCT01344837 2024-08-14

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

GOG Foundation

Completed
360 enrolled
Gynecologic

Endometrial Serous Adenocarcinoma

NCT03409692 2023-06-29

MMpredict

University of Turin, Italy

Completed
278 enrolled
Plasma cell

Multiple Myeloma

NCT05318391 2022-04-08

Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma

Shanghai Zhongshan Hospital

Completed
324 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡